The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Bos, Isabelle; Vos, Stephanie; Vandenberghe, Rik; Scheltens, Philip; Engelborghs, Sebastiaan; Frisoni, Giovanni; Molinuevo, José Luis; Wallin, Anders; Lleó, Alberto; Popp, Julius; Martinez-Lage, Pablo; Baird, Alison; Dobson, Richard; Legido-Quigley, Cristina; Sleegers, Kristel; Van Broeckhoven, Christine; Bertram, Lars; Ten Kate, Mara; Barkhof, Frederik; Zetterberg, Henrik; Lovestone, Simon; Streffer, Johannes; Visser, Pieter Jelle

doi:10.1186/s13195-018-0396-5

Scientific article

English

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Published inAlzheimer's Research and Therapy, vol. 10, no. 1, 64

Publication date2018

Abstract

There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. In this report we describe the design of the study, the methods used and the characteristics of the participants.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de psychiatrie

Research groups

Citation (ISO format)

BOS, Isabelle et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. In: Alzheimer’s Research and Therapy, 2018, vol. 10, n° 1, p. 64. doi: 10.1186/s13195-018-0396-5

Article (Published version)

CC BY

Identifiers

PID : unige:115255
DOI : 10.1186/s13195-018-0396-5
PMID : 29980228

Journal ISSN1758-9193

458views

0downloads

Creation24/10/2018 11:17:00

First validation24/10/2018 11:17:00

Update time15/03/2023 16:01:24

Status update15/03/2023 16:01:22

Last indexation31/10/2024 13:00:36

Archive ouverte UNIGE

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Technical informations